Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III adjuvant endocrine therapy trial in premenopausal hormone receptor-positive breast cancer
2004-000166-13Phase 3Terminated
- Sponsor
- International Breast Cancer Study Group
- Start
- May 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of exemestane, tamoxifen, triptorelin and goserelin in breast cancer (4 arms), sponsored by International Breast Cancer Study Group. Primary endpoint: Disease-free survival. Started May 2005; status: terminated.
02
Drugs
exemestanetamoxifentriptorelingoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000166-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000166-13.